RESMED INC — Director's Dealing 2014

Nov 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-11-03

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-03	ResMed Common Stock	M	2500	$15.52	Acquired	47297	Indirect
2014-11-03	ResMed Common Stock	S	2500	$52.00	Disposed	44797	Indirect
2014-11-03	ResMed Common Stock	M	5000	$18.67	Acquired	49797	Indirect
2014-11-03	ResMed Common Stock	S	5000	$51.751	Disposed	44797	Indirect
2014-11-03	ResMed Common Stock	S	500	$52.00	Disposed	44297	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-03	ResMed Common Stock Options	$15.52	M	2500	Disposed	2015-11-20	ResMed Common Stock (2500)	Indirect
2014-11-03	ResMed Common Stock Options	$18.67	M	5000	Disposed	2015-08-01	ResMed Common Stock (5000)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	72215	Direct

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.

F3: This transaction was executed in multiple trades at prices ranging from $51.54 to $52.00. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F4: Includes 250.774 shares purchased on October 31, 2014, through ResMed's Employee Stock Purchase Plan